US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PN Smart Energy Limited

2.42

-0.1700-6.56%

Post-market: 2.37-0.0497-2.05%16:11 EDT

Volume:392.18K

Turnover:1.02M

Market Cap:35.70M

PE:-0.42

High:2.86

Open:2.66

Low:2.29

Close:2.59

52wk High:40.00

52wk Low:1.77

Shares:14.75M

Float Shares:8.42M

Volume Ratio:1.54

T/O Rate:4.66%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8021

EPS(LYR):-2.0614

ROE:-33.34%

ROA:-12.30%

PB:1.17

PE(LYR):-1.17

Loading ...

Overview Company News Filings

Press Release: Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

Skycorp Solar regains Nasdaq compliance with $1 minimum bid price requirement

Garis Panduan Pertama Ahli Farmasi APAC untuk Menangani Neuropati Periferi

เปิดตัวแนวทางเวชปฏิบัติสำหรับเภสัชกรเพื่อรับมือโรคปลายประสาทอักเสบครั้งแรกในเอเชียแปซิฟิก

First Ever APAC Pharmacists' Guideline to Tackle Peripheral Neuropathy

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Skycorp Solar Group Ltd trading halted, news pending

Skycorp Solar implements 1-for-20 reverse stock split effective April 13

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/PN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PN\",,,,,undefined,":{"symbol":"PN","market":"US","secType":"STK","nameCN":"PN Smart Energy Limited","latestPrice":2.42,"timestamp":1791230400000,"preClose":2.59,"halted":0,"volume":392178,"hourTrading":{"tag":"盘后","latestPrice":2.3703,"preClose":2.42,"latestTime":"16:11 EDT","volume":1271,"amount":3019.3986577,"timestamp":1791231116803,"change":-0.0497,"changeRate":-0.020537,"amplitude":0.020537},"delay":0,"changeRate":-0.06563706563706562,"floatShares":8417500,"shares":14754000,"eps":-5.802095,"marketStatus":"Post-Mkt","change":-0.17,"latestTime":"10-05 16:13:39 EDT","open":2.66,"high":2.8601,"low":2.29,"amount":1018044.5951364001,"amplitude":0.220116,"askPrice":2.46,"askSize":5800,"bidPrice":2.37,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-5.802095,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1741064400000,"exchange":"NASDAQ","adjPreClose":2.59,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.59,"latestTime":"09:29 EDT","volume":8428,"amount":22273.468674800002,"timestamp":1791206999121,"change":0.01,"changeRate":0.003861,"amplitude":0.03861},"postHourTrading":{"tag":"盘后","latestPrice":2.3703,"preClose":2.42,"latestTime":"16:11 EDT","volume":1271,"amount":3019.3986577,"timestamp":1791231116803,"change":-0.0497,"changeRate":-0.020537,"amplitude":0.020537},"volumeRatio":1.540119},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PN\",,,,,undefined,":{"symbol":"PN","floatShares":8417500,"roa":"-12.30%","roe":"-33.34%","lyrEps":-2.06142,"volumeRatio":1.540119,"shares":14754000,"dividePrice":0,"high":2.8601,"amplitude":0.220116,"preClose":2.59,"low":2.29,"week52Low":1.7711,"pbRate":"1.17","psRate":"0.55","week52High":40,"institutionHeld":0,"latestPrice":2.42,"committee":-0.84127,"eps":-5.802095,"divideRate":0,"volume":392178,"delay":0,"ttmEps":-5.802095,"open":2.66,"prevYearClose":14.516,"prevWeekClose":2.59,"prevMonthClose":2.74,"prevQuarterClose":2.74,"fiveDayClose":2.62,"twentyDayClose":2.37,"sixtyDayClose":3.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"PN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-04-13","symbol":"PN","defaultRemindTime":1776087000000,"type":"split","dateTimestamp":1776052800000,"forFactor":20,"toFactor":1,"ratio":20},{"date":"2026-02-12","symbol":"PN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770886800000,"name":null,"time":"Pre-MKt","dateTimestamp":1770872400000,"actualEps":null},{"market":"US","date":"2025-09-08","symbol":"PN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1757304000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PN","date":"2026-10-02","current":-0.417091,"percent":0.29471,"low":-122.039266,"twenty":-8.383142,"median":143.316058,"eighty":658.805894,"high":992.177551,"avg":242.213097,"sd":303.721807,"marketCap":38225068},"quantilePoints":[{"date":"2025-03-07","current":218.413672,"twenty":221.509299,"median":227.299267,"eighty":241.802853,"marketCap":102870000},{"date":"2025-03-14","current":216.120615,"twenty":215.432698,"median":218.413672,"eighty":226.554024,"marketCap":101790000},{"date":"2025-03-21","current":214.974086,"twenty":214.74478,"median":217.840407,"eighty":223.401071,"marketCap":101250000},{"date":"2025-03-28","current":174.84559,"twenty":214.171516,"median":218.413672,"eighty":223.802356,"marketCap":82350000},{"date":"2025-04-04","current":196.629631,"twenty":205.707843,"median":216.693879,"eighty":223.802356,"marketCap":92610000},{"date":"2025-04-11","current":174.84559,"twenty":185.164346,"median":214.974086,"eighty":223.401071,"marketCap":82350000},{"date":"2025-04-17","current":144.462586,"twenty":175.992118,"median":213.827558,"eighty":222.942459,"marketCap":68040000},{"date":"2025-04-25","current":146.182379,"twenty":169.571559,"median":205.245792,"eighty":221.738604,"marketCap":68850000},{"date":"2025-05-02","current":139.876472,"twenty":146.182379,"median":196.629631,"eighty":219.789506,"marketCap":65880000},{"date":"2025-05-09","current":142.169529,"twenty":144.462586,"median":179.718336,"eighty":218.413672,"marketCap":66960000},{"date":"2025-05-16","current":143.241533,"twenty":143.318351,"median":174.84559,"eighty":217.95506,"marketCap":67464900},{"date":"2025-05-23","current":161.087249,"twenty":143.318351,"median":174.05162,"eighty":216.808532,"marketCap":75870000},{"date":"2025-05-30","current":166.246627,"twenty":143.435296,"median":166.533259,"eighty":216.020867,"marketCap":78300000},{"date":"2025-06-06","current":170.832741,"twenty":144.003975,"median":164.526834,"eighty":215.492317,"marketCap":80460000},{"date":"2025-06-13","current":161.087249,"twenty":144.462586,"median":163.380306,"eighty":214.859433,"marketCap":75870000},{"date":"2025-06-20","current":158.794192,"twenty":144.462586,"median":162.520409,"eighty":214.400822,"marketCap":74790000},{"date":"2025-06-27","current":148.475436,"twenty":144.462586,"median":162.233777,"eighty":213.827558,"marketCap":69930000},{"date":"2025-07-03","current":134.717094,"twenty":144.462586,"median":161.087249,"eighty":212.451724,"marketCap":63450000},{"date":"2025-07-11","current":144.462586,"twenty":143.775816,"median":159.914923,"eighty":208.466391,"marketCap":68040000},{"date":"2025-07-18","current":135.863623,"twenty":143.316058,"median":158.220928,"eighty":203.859639,"marketCap":63990000},{"date":"2025-07-25","current":171.979269,"twenty":143.316058,"median":158.708202,"eighty":199.725258,"marketCap":81000000},{"date":"2025-08-01","current":205.515227,"twenty":143.316058,"median":161.087249,"eighty":208.466391,"marketCap":96795000},{"date":"2025-08-08","current":142.169529,"twenty":143.316058,"median":161.087249,"eighty":205.923391,"marketCap":66960000},{"date":"2025-08-15","current":87.136163,"twenty":142.99503,"median":161.035655,"eighty":203.451475,"marketCap":41040000},{"date":"2025-08-22","current":59.906112,"twenty":140.908348,"median":158.42157,"eighty":199.725258,"marketCap":28215000},{"date":"2025-08-29","current":57.899687,"twenty":139.245882,"median":156.501135,"eighty":198.005465,"marketCap":27270000},{"date":"2025-09-05","current":59.046216,"twenty":137.927373,"median":155.927871,"eighty":197.088242,"marketCap":27810000},{"date":"2025-09-12","current":982.354011,"twenty":138.156679,"median":156.787767,"eighty":206.331555,"marketCap":27000000},{"date":"2025-09-19","current":835.885028,"twenty":138.672617,"median":158.622213,"eighty":214.056864,"marketCap":22974300},{"date":"2025-09-26","current":663.088958,"twenty":139.188555,"median":161.061452,"eighty":216.579226,"marketCap":18225000},{"date":"2025-10-03","current":671.438967,"twenty":139.647166,"median":161.087249,"eighty":219.674853,"marketCap":18454500},{"date":"2025-10-10","current":733.265381,"twenty":139.876472,"median":162.520409,"eighty":223.802356,"marketCap":20153799},{"date":"2025-10-17","current":696.292523,"twenty":140.22043,"median":163.95357,"eighty":232.630625,"marketCap":19137600},{"date":"2025-10-24","current":647.567764,"twenty":140.793695,"median":164.383518,"eighty":639.27257,"marketCap":17798400},{"date":"2025-10-31","current":687.647808,"twenty":141.710918,"median":166.246627,"eighty":658.4326,"marketCap":18900000},{"date":"2025-11-07","current":623.991268,"twenty":142.169529,"median":171.119373,"eighty":660.967073,"marketCap":17150400},{"date":"2025-11-14","current":704.05312,"twenty":142.169529,"median":173.699062,"eighty":660.967073,"marketCap":19350900},{"date":"2025-11-21","current":795.706749,"twenty":142.788655,"median":174.84559,"eighty":673.600146,"marketCap":21870000},{"date":"2025-11-28","current":776.059669,"twenty":143.217456,"median":177.711911,"eighty":681.193742,"marketCap":21330000},{"date":"2025-12-05","current":805.530289,"twenty":143.271343,"median":179.431704,"eighty":688.217573,"marketCap":22140000},{"date":"2025-12-12","current":741.677279,"twenty":143.316058,"median":188.317299,"eighty":696.410406,"marketCap":20385000},{"date":"2025-12-19","current":761.815536,"twenty":143.316058,"median":194.909838,"eighty":701.007822,"marketCap":20938500},{"date":"2025-12-26","current":720.06549,"twenty":143.317204,"median":197.776159,"eighty":713.621248,"marketCap":19791000},{"date":"2026-01-02","current":712.992541,"twenty":143.32179,"median":202.935537,"eighty":715.15372,"marketCap":19596600},{"date":"2026-01-09","current":762.208477,"twenty":143.889322,"median":209.831906,"eighty":720.06549,"marketCap":20949300},{"date":"2026-01-16","current":795.706749,"twenty":144.462586,"median":213.827558,"eighty":731.166091,"marketCap":21870000},{"date":"2026-01-23","current":471.136984,"twenty":144.462586,"median":214.974086,"eighty":731.585949,"marketCap":12949200},{"date":"2026-01-30","current":550.118246,"twenty":144.462586,"median":216.693879,"eighty":728.336911,"marketCap":15120000},{"date":"2026-02-06","current":471.529925,"twenty":144.462586,"median":218.413672,"eighty":721.578315,"marketCap":12960000},{"date":"2026-02-13","current":427.323995,"twenty":144.921197,"median":221.566625,"eighty":720.06549,"marketCap":11745000},{"date":"2026-02-20","current":-7.735293,"twenty":144.462586,"median":218.700304,"eighty":720.06549,"marketCap":20854080},{"date":"2026-02-27","current":-8.419249,"twenty":143.316058,"median":217.267143,"eighty":718.297253,"marketCap":22698000},{"date":"2026-03-06","current":-9.179585,"twenty":142.788655,"median":215.29798,"eighty":715.939603,"marketCap":24747840},{"date":"2026-03-13","current":-8.874062,"twenty":140.793695,"median":213.827558,"eighty":713.857013,"marketCap":23924160},{"date":"2026-03-20","current":-12.498679,"twenty":139.188555,"median":209.831906,"eighty":712.521011,"marketCap":33696000},{"date":"2026-03-27","current":-14.751913,"twenty":137.583415,"median":202.935537,"eighty":709.377479,"marketCap":39770640},{"date":"2026-04-02","current":-4.426615,"twenty":135.175706,"median":197.776159,"eighty":707.452065,"marketCap":11934000},{"date":"2026-04-10","current":-3.26528,"twenty":123.916796,"median":192.616781,"eighty":706.057122,"marketCap":8803080},{"date":"2026-04-17","current":-2.946604,"twenty":77.505324,"median":187.457403,"eighty":703.778061,"marketCap":7943940},{"date":"2026-04-24","current":-2.391173,"twenty":64.205594,"median":178.571807,"eighty":702.422412,"marketCap":6446520},{"date":"2026-05-01","current":-2.108751,"twenty":59.730693,"median":177.711911,"eighty":699.593232,"marketCap":5685120},{"date":"2026-05-08","current":-7.258247,"twenty":54.766225,"median":174.624884,"eighty":697.471348,"marketCap":19567980},{"date":"2026-05-15","current":-22.840471,"twenty":-2.153939,"median":171.979269,"eighty":697.432054,"marketCap":61577110},{"date":"2026-05-22","current":-21.809298,"twenty":-2.383679,"median":168.826316,"eighty":697.019465,"marketCap":58797105},{"date":"2026-05-29","current":-19.437602,"twenty":-2.483431,"median":166.103311,"eighty":696.4497,"marketCap":52403094},{"date":"2026-06-05","current":-15.673822,"twenty":-2.72349,"median":164.240202,"eighty":696.233582,"marketCap":42256076},{"date":"2026-06-12","current":-22.170209,"twenty":-3.936683,"median":163.95357,"eighty":695.329816,"marketCap":59770107},{"date":"2026-06-18","current":-17.890843,"twenty":-4.489109,"median":162.520409,"eighty":692.657813,"marketCap":48233086},{"date":"2026-06-26","current":-18.664222,"twenty":-5.102425,"median":161.087249,"eighty":688.531927,"marketCap":50318090},{"date":"2026-07-02","current":-20.107864,"twenty":-5.671035,"median":161.087249,"eighty":687.90322,"marketCap":54210097},{"date":"2026-07-10","current":-19.437602,"twenty":-7.483584,"median":158.708202,"eighty":687.667455,"marketCap":52403094},{"date":"2026-07-17","current":-19.695395,"twenty":-8.204341,"median":157.074399,"eighty":685.997453,"marketCap":53098095},{"date":"2026-07-24","current":-48.671343,"twenty":-8.436601,"median":156.214503,"eighty":684.445334,"marketCap":131216236},{"date":"2026-07-31","current":-122.039266,"twenty":-8.928223,"median":155.067974,"eighty":682.775332,"marketCap":329013591},{"date":"2026-08-07","current":-11.474374,"twenty":-9.170211,"median":154.093425,"eighty":678.786974,"marketCap":115231207},{"date":"2026-08-14","current":-3.875543,"twenty":-9.130632,"median":150.195228,"eighty":675.830089,"marketCap":38920070},{"date":"2026-08-21","current":-3.764813,"twenty":-9.049043,"median":148.475436,"eighty":674.425323,"marketCap":37808068},{"date":"2026-08-28","current":-3.917066,"twenty":-9.009464,"median":146.755643,"eighty":673.600146,"marketCap":39337070},{"date":"2026-09-04","current":-3.28037,"twenty":-8.928223,"median":145.895747,"eighty":672.22485,"marketCap":32943059},{"date":"2026-09-11","current":-3.363417,"twenty":-8.858786,"median":145.03585,"eighty":671.046025,"marketCap":33777060},{"date":"2026-09-18","current":-3.640242,"twenty":-8.703927,"median":144.462586,"eighty":667.509551,"marketCap":36557065},{"date":"2026-09-25","current":-3.875543,"twenty":-8.471306,"median":143.889322,"eighty":661.674368,"marketCap":38920070},{"date":"2026-10-02","current":-3.806336,"twenty":-8.383142,"median":143.316058,"eighty":658.805894,"marketCap":38225068}],"updateTime":1791231219407},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630586568","title":"Press Release: Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2630586568","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630586568?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:54","pubTimestamp":1777388040,"startTime":"0","endTime":"0","summary":"SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma  announced its results for the first quarter of 2026 . During the reporting period, the Company achieved a total revenue of RMB 10,073 million, representing a year-on-year increase of 6.93%. Regarding R&D investment, the Company firmly implemented its innovation transformation strategy. During the reporting period, the R&D expenditure increased to RMB 897 million, increased by 1.59% YoY. While increasing the R&D intensity, the Company maintained a positive growth trend in profit. Net profit attributable to shareholders of the list company after deducting extraordinary gain or loss was RMB 501 million, up 21.96% year-on-year. Net profit attributable to shareholders of the listed company was RMB 871 million, increased by 13.87% YoY. Net cash flows generated from operating activities was RMB 1,149 million, up 8.8% YoY.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK0183","BK4022","BK1515","BK0175","PN","BK4555","AIYY","BK4008","BK4551","BK0012","BK4500","BK1191","CHAT","BK4543","BK0187","BK4232","ALK","BK4587","BK4585","AI","600196","BK0096","AGIX","AIPO","ARTY","02196","BK1593","BK4588","BK4604","BK0060","BK0196","BK4096","BK4528","R","03160","BK0188","BK4099","BK0028","BK0239","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630630199","title":"Skycorp Solar regains Nasdaq compliance with $1 minimum bid price requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630630199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630630199?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:07","pubTimestamp":1777378027,"startTime":"0","endTime":"0","summary":"Skycorp Solar regained compliance with Nasdaq minimum bid price requirement, removing near-term delisting risk.Nasdaq confirmed Class A ordinary shares closed at or above USD 1 for 10 consecutive business days from April 13 to April 24.Nasdaq notification closed a deficiency first flagged on Oct. 30, 2025, tied to shares trading below USD 1 for 30 consecutive business days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skycorp Solar Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL184k8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4096","PN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628527929","title":"Garis Panduan Pertama Ahli Farmasi APAC untuk Menangani Neuropati Periferi","url":"https://stock-news.laohu8.com/highlight/detail?id=2628527929","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628527929?lang=en_us&edition=fundamental","pubTime":"2026-04-17 16:33","pubTimestamp":1776414780,"startTime":"0","endTime":"0","summary":"Dibangunkan oleh Pakar Farmasi APAC- 1 daripada 2 pesakit diabetes, dan 1 daripada 10 orang dewasa menghidap Neuropati Periferi[1],[2]- Ahli farmasi komuniti merupakan titik hubungan penjagaan kesihatan pertama dan paling mudah diakses- Garis panduan baharu menekankan peranan baru muncul bagi ahli farmasi dalam meningkatkan standard penjagaanKUALA LUMPUR, Malaysia,17 April 2026/PRNewswire/ -- Pakar farmasi Asia Pasifik bersama P&G Health mengumumkan garis panduan pertama rantau ini yang direka khusus untuk ahli farmasi komuniti bagi mengenal pasti, menilai dan mengurus pesakit dengan neuropati periferi  dalam amalan farmasi harian.Dr. Yolanda R. Robles, Profesor Kolej Farmasi, University of the Philippines dan Presiden Federation of Asian Pharmaceutical Associations ,berkata,\"PN merupakan keadaan yang meluas dan sering melemahkan, dengan prevalens tinggi dalam kalangan pesakit diabetes di APAC[3-7]— Filipina (58%), Indonesia (58%), Malaysia (54%), Thailand (34%), Singapura (28%) dan Au","market":"us","thumbnail":"https://mma.prnewswire.com/media/2958439/First_Ever_APAC_Pharmacists__Guideline_to_Tackle_PN.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2958439/First_Ever_APAC_Pharmacists__Guideline_to_Tackle_PN.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/garis-panduan-pertama-ahli-farmasi-apac-untuk-menangani-neuropati-periferi-302745763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU1868837300.USD","IE00BKDWB100.SGD","BK4558","PG","BK4585","LU0098860793.USD","SG9999014575.USD","LU0320765646.SGD","BK4588","BK4559","BK4018","LU0234572021.USD","LU1868836757.USD","BK4533","LU0096364046.USD","LU2129689605.HKD","BK4534","IE00BN8TJ469.HKD","IAI","BK4581","LU1868836914.USD","LU1066051498.USD","LU0061475181.USD","LU0868494708.USD","LU1868836591.USD","LU1585245621.USD","LU1430594728.SGD","BK4567","BK4096","IE00BLSP4452.SGD","LU1162221912.USD","LU2242646821.SGD","APAC","LU2097829019.USD","SG9999014542.SGD","LU0868494617.USD","SG9999014559.SGD","IE00B1XK9C88.USD","LU2129689431.USD","LU1929549753.HKD","SG9999001440.SGD","IE00BLSP4239.USD","LU2552382132.HKD","LU0237698245.USD","PN","SG9999002232.USD","LU0323591593.USD","LU0234570918.USD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628249182","title":"เปิดตัวแนวทางเวชปฏิบัติสำหรับเภสัชกรเพื่อรับมือโรคปลายประสาทอักเสบครั้งแรกในเอเชียแปซิฟิก","url":"https://stock-news.laohu8.com/highlight/detail?id=2628249182","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628249182?lang=en_us&edition=fundamental","pubTime":"2026-04-17 12:00","pubTimestamp":1776398400,"startTime":"0","endTime":"0","summary":"พัฒนาโดยคณะผู้เชี่ยวชาญด้านเภสัชกรรมในภูมิภาคเอเชียแปซิฟิก- เผยสถิติผู้ป่วยเบาหวาน 1 ใน 2 ราย และผู้ใหญ่ 1 ใน 10 ราย เผชิญกับโรคปลายประสาทอักเสบ [1],[2]-...","market":"us","thumbnail":"https://mma.prnewswire.com/media/2958441/First_Ever_APAC_Pharmacists__Guideline_to_Tackle_PN.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2958441/First_Ever_APAC_Pharmacists__Guideline_to_Tackle_PN.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/-302745475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PN","BK4582","BK4096","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627263722","title":"First Ever APAC Pharmacists' Guideline to Tackle Peripheral Neuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2627263722","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627263722?lang=en_us&edition=fundamental","pubTime":"2026-04-16 12:00","pubTimestamp":1776312000,"startTime":"0","endTime":"0","summary":"Developed By APAC Pharmacist Experts- 1 in 2 diabetics, and 1 in 10 adults suffer from Peripheral Neuropathy [1],[2]- Community pharmacists first and most accessible point of healthcare contact- New guidelines highlight emerging role of pharmacists in elevating the standard of careSINGAPORE, April 16, 2026 /PRNewswire/ --Leading Asia-Pacific pharmacist experts, together with P&G Health, announced the region's first guideline designed for community pharmacists to identify, assess, and manage patients with peripheral neuropathy  in everyday pharmacy practice.P&G Nerve Connect, a one-stop centre for pharmacists. The \"Empowering Community Pharmacists - Expert Consensus Guidelines for the Effective Management of Peripheral Neuropathy with Neurotropic B Vitamins' translates evidence into practical, culturally adaptable recommendations to standardize pharmacy-based screening, counselling, and stepwise management—narrowing the persistent gap of underdiagnosis and delayed treatment.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2957013/First_Ever_APAC_Pharmacists__Guideline_to_Tackle_PN.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2957013/First_Ever_APAC_Pharmacists__Guideline_to_Tackle_PN.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/first-ever-apac-pharmacists-guideline-to-tackle-peripheral-neuropathy-302744074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","PG","LU1066053197.SGD","IE00BBT3K403.USD","GB00BDT5M118.USD","LU2552382132.HKD","IE00BLSP4239.USD","LU0868494708.USD","LU0094547139.USD","BK4018","LU1868836591.USD","LU0323591593.USD","LU1162221912.USD","SG9999014542.SGD","LU2242646821.SGD","BK4581","LU1868837300.USD","LU0098860793.USD","BK4567","LU1430594728.SGD","BK4504","LU2097829019.USD","BK4585","LU0689626769.HKD","LU0868494617.USD","APAC","LU1585245621.USD","LU0124676726.USD","IE000M9KFDE8.USD","SG9999014567.USD","LU1914381329.SGD","BK4550","LU0640476718.USD","IE00BKDWB100.SGD","LU0061475181.USD","LU0942090050.USD","IE00BWXC8680.SGD","LU2129689514.USD","IE00B3T34201.USD","PN","SG9999002224.SGD","IE00B1XK9C88.USD","SG9999001440.SGD","BK4534","IE00BLSP4452.SGD","BK4533","SG9999015358.SGD","LU1868836914.USD","IAI","BK4096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627433481","title":"Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627433481","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627433481?lang=en_us&edition=fundamental","pubTime":"2026-04-13 13:00","pubTimestamp":1776056400,"startTime":"0","endTime":"0","summary":"Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/13/3272191/0/en/Dupixent-dupilumab-Approved-in-the-EU-as-the-First-Targeted-Medicine-to-Treat-Young-Children-with-Chronic-Spontaneous-Urticaria-CSU.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2106854487.HKD","BPH","LU2362540622.SGD","BK4007","LU0889565916.HKD","PN","BK4585","VHT","LU0114720955.EUR","LU1974910355.USD","BK4156","BK4096","IE00BFXG1179.USD","LU1162221912.USD","LU2362541513.USD","BK4550","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","LU0053666078.USD","LU0823434740.USD","EC","SNY","BK4201","BK4588","BP","LU0072461881.USD","LU0289739699.SGD","LU0882574055.USD","LU0162691827.USD","IXJ","LU0320765646.SGD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","LU0109394709.USD","LU1829250122.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626149884","title":"Skycorp Solar Group Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2626149884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626149884?lang=en_us&edition=fundamental","pubTime":"2026-04-11 07:50","pubTimestamp":1775865015,"startTime":"0","endTime":"0","summary":"19:50 EDT Skycorp Solar (PN) Group Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/skycorp-solar-group-ltd-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/skycorp-solar-group-ltd-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4096","PN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626243924","title":"Skycorp Solar implements 1-for-20 reverse stock split effective April 13","url":"https://stock-news.laohu8.com/highlight/detail?id=2626243924","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626243924?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:02","pubTimestamp":1775678556,"startTime":"0","endTime":"0","summary":"Nasdaq trading shifts to split-adjusted basis at market open April 13 under ticker PN.Outstanding Class A ordinary shares expected to fall to about 1,286,750 from 25,735,000.Post-split shares will trade under new CUSIP G8221K138.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skycorp Solar Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLbg16Lp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4096","PN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":68,"code":"91000000","status":"200"}]}}